PortViewPortView
ProSomnus logo

ProSomnus (OSA) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.47+0.00%
1-year price historyRange $0.02 – $5.04
52-week range$0.47
$0.47$0.50

What ProSomnus does

ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA). This enterprise, which originated in 2016, maintains its headquarters in Pleasanton, California.

Key metrics

Market cap
$8.18M
P/E (TTM)
-0.32
EPS (TTM)
$-1.49
Beta
0.21
Dividend yield
0.00%
Revenue / share
$1.71
50-day avg
$0.47
200-day avg
$0.47
52-week high
$0.50
52-week low
$0.47
CEO
Leonard Liptak

ETFs linked to OSA

Broad-market and Healthcare sector ETFs an investor holding ProSomnus is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OSA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for ProSomnus?
ProSomnus trades under the ticker OSA on NASDAQ.
Which exchange is OSA listed on?
OSA is listed on NASDAQ.
What sector does ProSomnus operate in?
ProSomnus is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze OSA in a portfolio?
PortView shows OSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.